E-Briefings

Trends affecting hospitals and health systems worldwide are forcing them to alter how they are structured and how they deliver care. Here’s how precision medicine factors in…

Studies by KHN, Navigant, and others report that independent rural hospitals are closing at record rates, leaving patients without critical nearby healthcare services, including precision medicine’s benefits…

Temple University All of Us lead investigators discuss the clinical and business reasons and community impact of joining the NIH precision medicine research project…

Daryl Pritchard, PhD, discusses the untapped potential of multi-gene panel sequencing and targeted therapies for patients with advanced cancer….

Charis Eng, MD, PhD, explains how the Cleveland Clinic is overcoming workforce challenges in clinical cancer genetics…

From research and development to pricing and access, the discourse on precision medicine is expanding, reflecting the emergence of new and multiple ideas of precision medicine aims in relation to healthcare economics, payment models, and patient outcomes…

Paul S. Appelbaum, MD, provides deeper insights into risks, privacy, and safeguarding patients’ genetic information…

Joshua C. Denny, MD, explains the importance of diverse genetic data in fueling precision-medicine breakthroughs…

Pioneer in precision prevention explains the shift to precision medicine in primary care, and the work of Sanford Imagenetics in creating precision medicine modules for physicians…

Walking the fine line between not being the biggest risk taker and not being the last adopter, hospitals that offer genetic testing can expect their market share to increase and their payer mix to improve, according to LSUHSC’s Miele…

Lori Anderson of XIFIN to share views on the current state of informatics in precision medicine as well as challenges and future trends for this field…

Michael Astion, MD, PhD, to share how the philosophy of the “two rights” can drive alignment and compromise among payers, providers, and patients…

Mary Zutter, MD, to share Vanderbilt’s lessons learned in assembling resources, selecting disease targets, and engaging physicians in precision medicine pursuits…

Olivier Elemento, PhD, to share what whole exome sequencing, whole genome sequencing, and artificial intelligence will mean to medicine and patient care…

Phil Febbo, MD, CMO of sequencing company Illumina, to discuss what company is doing to make it easier for health systems to adopt next-generation sequencing…

Mayo Clinic professor Richard Weinshilboum, MD, describes a near future in which preemptive gene sequencing becomes standard of care for safe and effective drug therapies…

It’s been a little more than a year since Geisinger launched its National Precision Health Initiative, a first-of-its kind unit designed to advance the promise of anticipatory medicine at Geisinger and at healthcare systems throughout the United States…

Rapidly falling costs and the increasing clinical value of human genome sequencing and genetic testing is reaching the point where innovative hospitals and health networks are ready to offer these services to patients in family practice settings…

Prominent health networks/hospitals participate in NIH genetic research supported by more than one billion dollars in funding from the federal government…

Ongoing growth in consumer genetic testing pressures hospitals and healthcare networks to educate and prepare their primary care physicians for informed patients…